✦ LIBER ✦

406 THE DYNAMIC ANALYSIS OF REGULATORY T CELLS IN PATIENTS WITH CHRONIC HEPATITIS C TREATED BY PEGYLATED INTERFERON AND RIBAVIRIN

✍ Scribed by O. Cai; X. Shao; Z. Zhao; Z. Gao

Book ID: 117379551
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 41 KB
Volume: 54
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(11)60408-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

IL28B rs12979860 C/T polymorphism in eld

IL28B rs12979860 C/T polymorphism in elderly chronic hepatitis C patients treated with pegylated-interferon and ribavirin

✍ E. G. Giannini; S. Marenco; I. Baldissarro; V. Fazio 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

The expression kinetics of CD137 in chro

The expression kinetics of CD137 in chronic hepatitis C patients treated with pegylated-interferon and ribavirin

✍ Lee, Sang Jin; Shin, Jung Woo; Park, Bo Ryung; Kim, Chang Jae; Jung, Seok Won; K 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 244 KB

Prevalence and impact of occult hepatiti

Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin

✍ Marion Levast; Sylvie Larrat; Marie-Ange Thelu; Sandrine Nicod; Agnès Plages; Al 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

## Abstract The prevalence of occult hepatitis B, defined by absence of HBsAg and HBV DNA, ranges widely in patients with hepatitis C. This may influence the treatment of hepatitis C and the severity of liver disease. Sensitive and specific real‐time PCR techniques are available commercially and ca

421 Hepatitis C virus (HCV)-specific CD4

421 Hepatitis C virus (HCV)-specific CD4+ and CD8+ T cell responses in patients with chronic hepatitis C treated with pegylated interferon plus ribavirin

✍ L. Capa; J. Garcia-Samaniego; V. Soriano; M. Romero; M. Núnez; C. de Mendoza; A. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Incidence and characterization of serum

Incidence and characterization of serum transaminases elevations in pegylated interferon and ribavirin treated patients with chronic hepatitis C

✍ P. H. THURAIRAJAH; D. THORBURN; S. HUBSCHER; A. WHITE; W. K. LAI; K. O’DONNELL; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 528 KB

Cost-effectiveness of pegylated interfer

Cost-effectiveness of pegylated interferon and ribavirin for patients with chronic hepatitis C treated in routine clinical practice

✍ Grishchenko, Marina; Grieve, Richard D.; Sweeting, Michael J.; De Angelis, Danie 📂 Article 📅 2009 🏛 Cambridge University Press 🌐 English ⚖ 189 KB